Menu Back toPanel discussion: Digital Transformation in Regulatory Affairs

DIA Asia 2021-The Evolution Of Clinical Trials And Regulatory Science In A Post-Pandemic Digital World In Asia

The timing is as per Singapore Time Zone


Panel discussion: Digital Transformation in Regulatory Affairs

Speaker(s)

Shimon  Yoshida, PhD

Shimon Yoshida, PhD

  • Executive Director, International Labeling Group, Global Regulatory Affairs
  • Pfizer Inc, United Kingdom
Tomoko  Ohsawa, PhD

Tomoko Ohsawa, PhD

  • Director of Office of Informatics and Management for Safety
  • Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Kai  Langel

Kai Langel

  • Senior Director, Strategy and Innovation, Global Regulatory Policy
  • Janssen, Spain
Tong  Guo

Tong Guo

  • Executive Vice President
  • LinkDoc Technology (Beijing) Co. Ltd, China

Contact us

Registration Questions?


Send Email
+91 9029098844